Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
To use high dose chemotherapy with autologous stem cell rescue to try to increase the chance
of long term control and cure of the disease.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Disease free survival (DFS)
United States: Institutional Review Board
|Stanford University School of Medicine||Stanford, California 94305-5317|